e.g., HRA000087; HRA000150
  1. Home
  2. Browse
  3. HRA000968
HRA000968
   HRA000968.xlsx
Title:
Strategy for NK cell activation by epigentic compound screening
Release date:
2021-12-06
Description:
Primary human NK cells were treated with DMSO or Daphnetin in the presence of IL-12 (10 ng/ml) for 12 hours.
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA005273
Study type:
Medical
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000542
DAC name:
HRA001286
Contact person:
Deng Youcai
Email:
youcai.deng@tmmu.edu.cn
Description:
Strategy for NK cell activation by epigentic compound screening
Individuals & samples
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
Individual Accession
Individual Name
Gender
Sample Accession
Sample Name
Sample Description
HRI132710con4not collectedHRS208383con4Primary human NK cells were treated with DMSO in the presence of IL-12 (10 ng/ml) for 12 hours.
HRI132711Da4not collectedHRS208384Da4Primary human NK cells were treated with Daphnetin in the presence of IL-12 (10 ng/ml) for 12 hours.
HRI132712con6not collectedHRS208385con6Primary human NK cells were treated with DMSO in the presence of IL-12 (10 ng/ml) for 12 hours.
HRI132713Da6not collectedHRS208386Da6Primary human NK cells were treated with Daphnetin in the presence of IL-12 (10 ng/ml) for 12 hours.
HRI132714con7not collectedHRS208387con7Primary human NK cells were treated with DMSO in the presence of IL-12 (10 ng/ml) for 12 hours.
HRI132715Da7not collectedHRS208388Da7Primary human NK cells were treated with Daphnetin in the presence of IL-12 (10 ng/ml) for 12 hours.
Showing 1 to 6 of 6 rows rows per page
Files
Request Data
Run accession
Files
Experiment
Experiment title
Platform
Sample
Run accession
Files
Experiment
Experiment title
Platform
Sample
HRR272871HRR272871_f1.fq.gz (1.60 GB)HRX230699con4Illumina HiSeq 2500HRS208383 (SAMC1836723)
HRR272871HRR272871_r2.fq.gz (1.66 GB)HRX230699con4Illumina HiSeq 2500HRS208383 (SAMC1836723)
HRR272872HRR272872_f1.fq.gz (1.53 GB)HRX230700Da4Illumina HiSeq 2500HRS208384 (SAMC1836730)
HRR272872HRR272872_r2.fq.gz (1.62 GB)HRX230700Da4Illumina HiSeq 2500HRS208384 (SAMC1836730)
HRR272873HRR272873_f1.fq.gz (1.62 GB)HRX230701con6Illumina HiSeq 2500HRS208385 (SAMC1836735)
HRR272873HRR272873_r2.fq.gz (1.69 GB)HRX230701con6Illumina HiSeq 2500HRS208385 (SAMC1836735)
HRR272874HRR272874_f1.fq.gz (1.52 GB)HRX230702Da6Illumina HiSeq 2500HRS208386 (SAMC1836739)
HRR272874HRR272874_r2.fq.gz (1.61 GB)HRX230702Da6Illumina HiSeq 2500HRS208386 (SAMC1836739)
HRR272875HRR272875_f1.fq.gz (1.57 GB)HRX230703con7Illumina HiSeq 2500HRS208387 (SAMC1836745)
HRR272875HRR272875_r2.fq.gz (1.65 GB)HRX230703con7Illumina HiSeq 2500HRS208387 (SAMC1836745)
Showing 1 to 10 of 12 rows rows per page
Submitter:   Deng Youcai / youcai.deng@tmmu.edu.cn
Organization:   Army Medical University (Third Military Medical University)
Submission date:   2021-06-22
Requests:   -